International Biotechnology Trust plc
Portfolio Analysis
31 March 2012 |
Summary
IBT Portfolio NAV (m)
£118.8
Number of Portfolio Companies
66
Quoted Investments
40
Unquoted Investments
26
Quoted / Unquoted Split
NAV by Geography
Quoted
75%
United States / Canada
70%
Unquoted
16%
Europe
13%
Cash
9%
Middle East
4%
Total
100%
Australia
4%
Cash
9%
Total
100%
NAV by Subsector
NAV by Market Capitalisation
Therapeutics
68%
Large-Cap (>$10bn)
26%
Medical Devices
7%
Mid-Cap (>$1bn, <$10bn)
22%
Specialty Pharma
8%
Small-Cap (<$1bn)
27%
Life Sciences, Tools
8%
Unquoted
16%
Cash
9%
Cash
9%
Total
100%
Total
100%
NAV by Development Phase
Marketed
56%
Regulatory
6%
Phase 3
9%
Phase 2
12%
Phase 1
4%
Other
4%
Cash
9%
Total
100%